Off-label Use of Gastrointestinal Multiplex PCR Panel for the Diagnosis of Amoebic Liver Abscess: A Three-case Pediatric Report - Scorecard - MDSpire

Off-label Use of Gastrointestinal Multiplex PCR Panel for the Diagnosis of Amoebic Liver Abscess: A Three-case Pediatric Report

  • By

  • Michael Muñoz-Rosa

  • Natalia Arango-Serna

  • Juan Mesa-Monsalve

  • Alejandro Diaz-Diaz

  • October 15, 2025

  • 0 min

Share

Clinical Scorecard: Utilization of Gastrointestinal Multiplex PCR Panel for Diagnosing Amoebic Liver Abscess: A Report on Three Pediatric Cases

At a Glance

CategoryDetail
ConditionAmoebic liver abscess caused by Entamoeba histolytica
Key MechanismsInvasive infection by E. histolytica leading to liver abscess formation; detection of pathogen genetic material via multiplex PCR
Target PopulationPediatric patients with suspected liver abscess
Care SettingResource-limited, high-burden settings; hospital with imaging and surgical drainage capabilities

Key Highlights

  • Off-label use of FilmArray Gastrointestinal® multiplex PCR panel on liver abscess fluid enabled rapid and accurate diagnosis of E. histolytica.
  • Traditional diagnostic methods (immunodiagnosis, microscopy, cultures) have limitations including delayed antibody detection and false negatives.
  • Targeted antiamoebic therapy guided by PCR results led to favorable clinical outcomes in all three pediatric cases.

Guideline-Based Recommendations

Diagnosis

  • Consider amoebic liver abscess in patients with right lobe liver abscesses unresponsive to empirical antibiotics, especially with relevant epidemiological risk factors.
  • Use imaging (ultrasound) for lesion detection but rely on molecular diagnostics for etiological confirmation.
  • Employ multiplex PCR panels on liver abscess fluid as a rapid diagnostic tool, acknowledging current off-label status and need for further validation.

Management

  • Initiate empirical antibiotic therapy covering bacterial pathogens initially; add metronidazole when amoebic etiology is suspected.
  • Adjust treatment to targeted antiamoebic therapy upon confirmation of E. histolytica by PCR.
  • Perform surgical or percutaneous drainage for large or non-resolving abscesses.

Monitoring & Follow-up

  • Monitor clinical signs, inflammatory markers, and abscess size via imaging to assess treatment response.
  • Reassess therapy if clinical deterioration or abscess enlargement occurs.

Risks

  • Delayed or inaccurate diagnosis may lead to inappropriate antibiotic use and increased morbidity.
  • Off-label use of multiplex PCR requires cautious interpretation pending further validation.
  • Potential complications include intestinal necrosis, peritonitis, and toxic megacolon if untreated.

Patient & Prescribing Data

Three pediatric patients aged 17 months to 5 years with liver abscesses

Empirical broad-spectrum antibiotics were initially used; metronidazole was added upon suspicion or confirmation of amoebic infection. PCR confirmation allowed discontinuation of unnecessary antibiotics and continuation of targeted antiamoebic therapy.

Clinical Best Practices

  • Use multiplex PCR panels on liver abscess fluid to rapidly identify E. histolytica in suspected cases.
  • Combine clinical, epidemiological, and imaging data to guide suspicion and management of amoebic liver abscess.
  • Perform abscess drainage when indicated to obtain diagnostic material and aid treatment.
  • Adjust antimicrobial therapy based on molecular diagnostic results to avoid unnecessary antibiotic exposure.

References

Original Source(s)

Related Content